(19)
(11) EP 2 054 042 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.06.2020 Bulletin 2020/24

(45) Mention of the grant of the patent:
29.04.2020 Bulletin 2020/18

(21) Application number: 07719147.6

(22) Date of filing: 29.06.2007
(51) International Patent Classification (IPC): 
A61K 9/51(2006.01)
A61P 25/18(2006.01)
A61K 31/5513(2006.01)
A61K 31/196(2006.01)
A61K 31/435(2006.01)
A61K 31/216(2006.01)
A61K 31/519(2006.01)
A61K 9/14(2006.01)
A61K 31/4985(2006.01)
A61K 31/192(2006.01)
A61P 29/00(2006.01)
A61P 15/10(2006.01)
A61P 19/10(2006.01)
A61K 31/4535(2006.01)
A61K 31/551(2006.01)
(86) International application number:
PCT/AU2007/000910
(87) International publication number:
WO 2008/000042 (03.01.2008 Gazette 2008/01)

(54)

METHODS FOR THE PREPARATION OF BIOLOGICALLY ACTIVE COMPOUNDS IN NANOPARTICULATE FORM

VERFAHREN ZUR HERSTELLUNG VON BIOLOGISCHEN WIRKSTOFFEN IN NANOTEILCHENFORM

PROCÉDÉS DE PRÉPARATION DE COMPOSÉS BIOLOGIQUEMENT ACTIFS SOUS FORME DE NANOPARTICULES


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 30.06.2006 AU 2006903527 P
04.05.2007 US 915955 P

(43) Date of publication of application:
06.05.2009 Bulletin 2009/19

(73) Proprietor: iCeutica Pty Ltd
Iluka, WA 6028 (US)

(72) Inventors:
  • MEISER, Felix
    Kew, Victoria 3101 (AU)
  • CAMMARANO, Raffaele
    Mount Hawthorn, Western Australia 6016 (AU)
  • CARUSO, Frank
    Camberwell, Victoria 3124 (AU)
  • POSTMA, Almar
    Balwyn, Victoria 3103 (AU)

(74) Representative: Murgitroyd & Company 
Murgitroyd House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)


(56) References cited: : 
EP-A2- 0 371 431
WO-A1-01/03670
WO-A1-2006/069419
WO-A2-2007/070851
US-A1- 2004 058 009
EP-B1- 0 600 528
WO-A1-2006/060698
WO-A2-02/094215
US-A- 5 202 129
US-A1- 2005 019 412
   
  • M. JUHNKE ET AL: "Nanoparticles of soft materials by high-energy milling at low temperatures", 7TH WORLD CONGRESS OF CHEMICAL ENGINEERING, GLASGOW, 1 January 2005 (2005-01-01), pages 1-10, XP55031954,
  • ITOH K ET AL: "NANOPARTICLE FORMATION OF POORLY WATER-SOLUBLE DRUGS FROM TERNARY GROUND MIXTURES WITH PVP AND SDS", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, JP, vol. 51, no. 2, 1 February 2003 (2003-02-01), pages 171-174, XP001144319, ISSN: 0009-2363, DOI: 10.1248/CPB.51.171
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).